Claritas Pharmaceuticals, Inc.

OTCPK:CLAZ.F Stock Report

Market Cap: US$675.8k

Claritas Pharmaceuticals Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Claritas Pharmaceuticals's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Claritas Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CLAZ.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 21022-2
30 Jun 21022-2
31 Mar 210-122-2
31 Dec 20042-2
30 Sep 200-720
30 Jun 200-821
31 Mar 200-133
31 Dec 190-2146
30 Sep 190-1248
30 Jun 190-949
31 Mar 190239
31 Dec 180738
30 Sep 180-2136
30 Jun 180-2434
31 Mar 180-3233
31 Dec 170-3232
30 Sep 170-1452
30 Jun 170-1352
31 Mar 170-1342
31 Dec 160-1232
30 Sep 160-321

Quality Earnings: CLAZ.F has a high level of non-cash earnings.

Growing Profit Margin: Insufficient data to determine if CLAZ.F's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if CLAZ.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare CLAZ.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if CLAZ.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.


Return on Equity

High ROE: CLAZ.F has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies